TNF and metabolic dysfunction-associated steatohepatitis: For example, oral cidomycin increased small intestine transit rates and reduced serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), and TNF-α in a NASH mouse model, which suggested that cidomycin may reduce the severity of NASH by modulating intestinal microbiota (59).